112 related articles for article (PubMed ID: 32620657)
1. The Impact of Hypertension on the Clinicopathological Outcome and Progression of Renal Cell Carcinoma.
Makino T; Izumi K; Iwamoto H; Kadomoto S; Naito R; Yaegashi H; Shigehara K; Kadono Y; Mizokami A
Anticancer Res; 2020 Jul; 40(7):4087-4093. PubMed ID: 32620657
[TBL] [Abstract][Full Text] [Related]
2. Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer.
Kocher NJ; Rjepaj C; Robyak H; Lehman E; Raman JD
World J Urol; 2017 Jan; 35(1):67-72. PubMed ID: 27189620
[TBL] [Abstract][Full Text] [Related]
3. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma.
Büttner F; Winter S; Rausch S; Hennenlotter J; Kruck S; Stenzl A; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
BMC Med; 2018 Jul; 16(1):108. PubMed ID: 29973214
[TBL] [Abstract][Full Text] [Related]
5. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
Sun J; Ning H; Sun J; Qu X
Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
7. Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma.
Kang M; Gong IH; Park HJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Choi HY; Il Seo S
J Endourol; 2017 Dec; 31(12):1231-1236. PubMed ID: 29048228
[TBL] [Abstract][Full Text] [Related]
8. Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.
Kume H; Homma Y; Shinohara N; Obara W; Kondo T; Kimura G; Fujimoto H; Nonomura N; Hongo F; Sugiyama T; Takahashi M; Kanayama HO; Fukumori T; Eto M
Jpn J Clin Oncol; 2019 Aug; 49(8):772-779. PubMed ID: 30977820
[TBL] [Abstract][Full Text] [Related]
9. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014.
Bai T; Wang L; Wang D; Yuan X; Bai W; Yang Q; Yang X
PLoS One; 2015; 10(12):e0144246. PubMed ID: 26633179
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival in Japanese patients with brain metastasis from renal cell cancer.
Takeshita N; Otsuka M; Kamasako T; Somoto T; Uemura T; Shinozaki T; Kobayashi M; Kawana H; Itami M; Iuchi T; Komaru A; Fukasawa S
Int J Clin Oncol; 2019 Oct; 24(10):1231-1237. PubMed ID: 31134469
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Chronic Kidney Disease Status is an Independent Prognostic Factor in Patients with Renal Cell Carcinoma.
Kim YW; Kim WT; Yun SJ; Lee SC; Kim WJ; Ha YS; Park YH; Kang SH; Hong SH; Kwon TG; Byun SS; Kwak C; Kim YJ
Ann Surg Oncol; 2015 Nov; 22(12):4098-103. PubMed ID: 25851339
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Tumor Pseudocapsule Status and its Prognostic Significance in Renal Cell Carcinoma.
Xi W; Wang J; Liu L; Xiong Y; Qu Y; Lin Z; Chen X; Wang Z; Xu J; Guo J
J Urol; 2018 Apr; 199(4):915-920. PubMed ID: 29128576
[TBL] [Abstract][Full Text] [Related]
14. Active surveillance for incidental renal mass in the octogenarian.
Celtik KE; Shah PH; Patel VR; Moreira DM; George AK; Iacovelli V; Alom M; Ng A; Herati A; Salami SS; Bierwiler H; Schwartz MJ; Richstone L; Steckel J; Vira MA; Kavoussi LR
World J Urol; 2017 Jul; 35(7):1089-1094. PubMed ID: 27803967
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.
Liu NW; Wren JD; Vertosick E; Lee JK; Power NE; Benfante NE; Kimm SY; Bains MS; Sjoberg DD; Russo P; Coleman JA
J Urol; 2016 Feb; 195(2):264-9. PubMed ID: 26363467
[TBL] [Abstract][Full Text] [Related]
16. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma.
Rautiola J; Donskov F; Peltola K; Joensuu H; Bono P
BJU Int; 2016 Jan; 117(1):110-7. PubMed ID: 25252180
[TBL] [Abstract][Full Text] [Related]
19. The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib.
Basappa NS; Elson P; Golshayan AR; Wood L; Garcia JA; Dreicer R; Rini BI
Cancer; 2011 Mar; 117(6):1183-9. PubMed ID: 20960527
[TBL] [Abstract][Full Text] [Related]
20. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
